ArticleFrontiers in medicine2022

A Somatic Mutation Signature Predicts the Best Overall Response to Anti-programmed Cell Death Protein-1 Treatment in Epidermal Growth Factor Receptor/Anaplastic Lymphoma Kinase-Negative Non-squamous Non-small Cell Lung Cancer.

Jie Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.